TY  - GEN
AU  - Pajares,Bella
AU  - Trigo,Jose M
AU  - Toledo,Maria D
AU  - Álvarez,Martina
AU  - González-Hermoso,Carlos
AU  - Rueda,Antonio
AU  - Medina,Jose A
AU  - de Luque,Vanessa
AU  - Jerez,Jose M
AU  - Alba,Emilio
TI  - Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer
SN  - 1471-2407
PY  - 2014///0110
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Carcinoma, Squamous Cell
KW  - metabolism
KW  - Cetuximab
KW  - Chemoradiotherapy
KW  - Cisplatin
KW  - Cyclin-Dependent Kinase Inhibitor p16
KW  - DNA, Viral
KW  - Disease-Free Survival
KW  - Dose Fractionation, Radiation
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Female
KW  - Gefitinib
KW  - Head and Neck Neoplasms
KW  - Human papillomavirus 16
KW  - genetics
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neoplasm Recurrence, Local
KW  - Panitumumab
KW  - Proportional Hazards Models
KW  - Quinazolines
KW  - Retrospective Studies
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2407-13-26
ER  -